BXRX
Vanguard Group’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-48,300
| Closed | -$17.9K | – | 4601 |
|
|
2023
Q3 | $17.9K | Buy |
48,300
+23,400
| +94% | +$8.66K | ﹤0.01% | 4505 |
|
|
2023
Q2 | $29.1K | Hold |
24,900
| – | – | ﹤0.01% | 4501 |
|
|
2023
Q1 | $42.3K | Buy |
+24,900
| New | +$42.3K | ﹤0.01% | 4488 |
|
|
2022
Q4 | – | Sell |
-58,320
| Closed | -$14K | – | 4634 |
|
|
2022
Q3 | $14K | Sell |
58,320
-1,061
| -2% | -$255 | ﹤0.01% | 4595 |
|
|
2022
Q2 | $50K | Sell |
59,381
-66,951
| -53% | -$56.4K | ﹤0.01% | 4587 |
|
|
2022
Q1 | $224K | Sell |
126,332
-3,524,644
| -97% | -$6.25M | ﹤0.01% | 4520 |
|
|
2021
Q4 | $800K | Sell |
3,650,976
-89,286
| -2% | -$19.6K | ﹤0.01% | 4323 |
|
|
2021
Q3 | $2.11M | Buy |
3,740,262
+12,462
| +0.3% | +$7.03K | ﹤0.01% | 4043 |
|
|
2021
Q2 | $2.84M | Sell |
3,727,800
-160,460
| -4% | -$122K | ﹤0.01% | 3858 |
|
|
2021
Q1 | $5.02M | Buy |
3,888,260
+3,393,054
| +685% | +$4.38M | ﹤0.01% | 3532 |
|
|
2020
Q4 | $500K | Buy |
495,206
+113,984
| +30% | +$115K | ﹤0.01% | 3949 |
|
|
2020
Q3 | $1.06M | Buy |
381,222
+3,371
| +0.9% | +$9.34K | ﹤0.01% | 3647 |
|
|
2020
Q2 | $1.57M | Sell |
377,851
-37,399
| -9% | -$155K | ﹤0.01% | 3504 |
|
|
2020
Q1 | $1.03M | Buy |
415,250
+36,293
| +10% | +$89.9K | ﹤0.01% | 3478 |
|
|
2019
Q4 | $2.62M | Buy |
+378,957
| New | +$2.62M | ﹤0.01% | 3371 |
|